Recent blog posts
IFNW1 Biologics Sequence Review Report 2026: Interferon omega-1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNW1 Biologics Sequence Review Report 2026: Interferon omega-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNW1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA7 Biologics Sequence Review Report 2026: Interferon alpha-7 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA7 Biologics Sequence Review Report 2026: Interferon alpha-7 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNL4 Biologics Sequence Review Report 2026: Interferon lambda-4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNL4 Biologics Sequence Review Report 2026: Interferon lambda-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNL4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA8 Biologics Sequence Review Report 2026: Interferon alpha-8 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA8 Biologics Sequence Review Report 2026: Interferon alpha-8 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA4 Biologics Sequence Review Report 2026: Interferon alpha-4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA4 Biologics Sequence Review Report 2026: Interferon alpha-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA2 Biologics Sequence Review Report 2026: Interferon alpha-2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA2 Biologics Sequence Review Report 2026: Interferon alpha-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA21 Biologics Sequence Review Report 2026: Interferon alpha-21 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA21 Biologics Sequence Review Report 2026: Interferon alpha-21 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFI30 Biologics Sequence Review Report 2026: Gamma-interferon-inducible lysosomal thiol reductase Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFI30 Biologics Sequence Review Report 2026: Gamma-interferon-inducible lysosomal thiol reductase Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFI30 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA17 Biologics Sequence Review Report 2026: Interferon alpha-17 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA17 Biologics Sequence Review Report 2026: Interferon alpha-17 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA17 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IFNA14 Biologics Sequence Review Report 2026: Interferon alpha-14 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IFNA14 Biologics Sequence Review Report 2026: Interferon alpha-14 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IFNA14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CFH Biologics Sequence Review Report 2026: Complement factor H Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CFH Biologics Sequence Review Report 2026: Complement factor H Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CFH protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
FZD9 Biologics Sequence Review Report 2026: Frizzled-9 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
FZD9 Biologics Sequence Review Report 2026: Frizzled-9 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FZD9 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →